22
Nov

Dr. Paul Shipley Of University Of British Columbia To Join Future Harvest Development As Research And Development Consultant

Investor Relations

Vancouver, BC, November 22, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) has successfully retained the services of Dr. Paul Shipley of the University of British Columbia (“UBC”) for the role of Research and Development Consultant for the Future Harvest Development (“FHD”) Product Development and Special Projects department.

The Company anticipates Dr. Shipley’s expertise and involvement will contribute to the formation of leading-edge agricultural growth supplements that improve cannabis plants’ health and yields while rebuilding surrounding soil structures, in accordance with FHD’s dedication to creating industry-leading products that offer long-term sustainability.

Dr. Shipley, Department of Chemistry Associate Professor at UBC Okanagan for the past 15 years, is President of the Natural Health Products Research Society of Canada, whose mission is to promote rigorous and meaningful research and education within the field of natural health product development. Dr. Shipley brings to FHD a passion for the chemistry of living systems, in particular medicinal plants and antibiotic-producing bacteria, and a lifelong devotion to ground-breaking research. Following his work alongside Justin Pearson, one of FHD’s leading bioengineers, Dr. Shipley feels confident in his ability to collaborate with FHD in the development of evidence-based cannabis growth supplements. Dr. Shipley partially accredits his excitement to working with FHD to this working relationship: “Observing Justin conduct industry-leading research with FHD and seeing the passion he held for his work inspired me to pursue a long-term commitment with FHD.”

Chris Pearson, FHD’s Chief Revenue Officer, also feels confident about Dr. Shipley’s involvement: “I had the opportunity to collaborate with Professor Shipley on a research project in 2013. There are few people that I hold in higher regard and I could not be happier with his appointment to the team.”

Invictus MD and FHD are committed to the scientific development of evidence-based nutrient formulations for agricultural use and for the cannabis industry. The Company is eager to develop a strong working relationship with Dr. Shipley and is grateful for his involvement, and look forward to maintaining FHD’s status within the cannabis industry as a leading innovator.

About Invictus MD Strategies Corp.
Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential.  We provide not only capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business, from establishing start-ups to running large international organizations.  The fundamental core of our operations centers on the vast opportunities within fragmented industries.

Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth.  Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman & CEO
604-368-6437

Cautionary Note Regarding Forward-Looking Statements:  This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed spin-out of Future Harvest, are forward-looking statements and contain forward-looking information.  Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”.  Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the proposed spin-out of Future Harvest will occur as anticipated, that the Company will obtain all requisite  approvals of the spin-out transaction, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed spin-out may not occur as planned; the timing and receipt requisite approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.  There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.  Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information.  Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.  We seek safe harbour.

Recent Posts

Invictus Hires Ex-Heineken Executive Kevin Smith As VP Recreational Sales; Sarah Hardy As VP Medical Sales

September 17, 2018

Invictus Acreage Pharms To Become A Registered Cannabis Supplier In Saskatchewan

September 11, 2018

Invictus Signs Arrangement Agreement For Spinout Of Poda And Announces Annual General And Special Meeting Date

September 11, 2018

Invictus Acreage Pharms Makes First Provincial Bulk Shipment Of Recreational Cannabis On Schedule

September 7, 2018
 

Categories

Archives

 September 2018
 August 2018
 July 2018
 June 2018
 May 2018
 April 2018
 March 2018
 February 2018
 January 2018
 December 2017
 November 2017
 October 2017
 September 2017
 August 2017
 July 2017
 June 2017
 May 2017
 April 2017
 March 2017
 February 2017
 January 2017
 December 2016
 November 2016
 October 2016
 August 2016
 March 2016
 February 2016
 December 2015
 November 2015
 October 2015
 September 2015

Download our Investor Deck





Download our Investor Deck